A double-blind, multicentre comparison of intravenous dolasteron mesilate and metoclopraminde in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy. - Chevallier,B.; Cappelaere,P.; Splinter,T.; Fabbro,M.; Wendling,J.L.; Cals,L.; Catimel,G.; Giovannini,M.; Khayat,D.; Bastis,P.; Claverie,N. (Support. Care Cancer, 1997)